{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:09:39Z","timestamp":1788862179992,"version":"build-2803163510"},"posted":{"date-parts":[[2026,7,25]]},"group-title":"In Review","reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,19]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Background\n Human papillomavirus (HPV)-based screening is increasingly being adopted as the primary strategy for cervical cancer prevention due to its superior sensitivity compared with cytology. However, effective triage of women who test positive for high-risk HPV (hrHPV), particularly those infected with non-HPV16\/18 genotypes, remains a significant challenge in low-resource settings. Cytology-based triage requires substantial laboratory infrastructure and technical expertise, which may limit its scalability. Risk-stratified triage approaches incorporating readily available clinical and demographic factors may offer a practical alternative for identifying women at highest risk of cervical precancer while reducing unnecessary referrals.\nAim\n The \u201c\n                  <italic>STRAT-CIN Trial<\/italic>\n                  \u201d aims to determine whether a risk-stratified triage algorithm is non-inferior to standard cytology-based triage for the detection of high-grade cervical intraepithelial neoplasia (CIN2+) among women positive for non-HPV16\/18 high-risk HPV types.\nMethods\n This protocol describes a two-arm, parallel, open-label, non-inferiority randomized controlled trial involving sexually active women aged 30\u201365 years who test positive for non-HPV16\/18 high-risk HPV types during routine cervical cancer screening at the Lagos University Teaching Hospital (LUTH), Lagos, Nigeria, between June 2026 and January 2027. A total of 148 eligible women will be randomized in a 1:1 ratio to either a risk-stratified triage arm or a cytology-based triage arm. Participants in the intervention arm will be triaged using a composite algorithm incorporating age, HIV status, cigarette smoking, long-term oral contraceptive use, and multiple hrHPV genotype infections, while participants in the control arm will undergo reflex cytology according to the Bethesda 2014 classification. The primary outcome is the proportion of histologically confirmed CIN2\u2009+\u2009lesions detected in each study arm. Secondary outcomes include diagnostic performance metrics, referral rates for colposcopy, colposcopic yield, and predictors of CIN2+. Analyses will follow the intention-to-treat principle. Differences in CIN2\u2009+\u2009detection rates will be assessed using risk differences and corresponding 95% confidence intervals. Non-inferiority will be concluded if the lower bound of the confidence interval exceeds the pre-specified non-inferiority margin of \u2212\u200910%. Logistic regression analyses will be used to identify independent predictors of CIN2+, and statistical significance will be set at P\u2009&lt;\u20090.05.\nDiscussion\n The \u201c\n                  <italic>STRAT-CIN Trial<\/italic>\n                  \u201d will evaluate whether a simplified risk-stratified triage approach can achieve diagnostic performance comparable to conventional cytology-based triage among women with non-HPV16\/18 high-risk HPV infections. By integrating easily obtainable clinical and demographic risk factors into triage decision-making, this study has the potential to reduce unnecessary colposcopy referrals, improve screening efficiency, and support the implementation of context-appropriate cervical cancer prevention strategies in resource-constrained settings. The findings will contribute important evidence toward optimizing HPV-based cervical cancer screening programs in Nigeria and other low- and middle-income countries.\nRegistration\n : PACTR202606895128487 (2nd June 2026).\n                <\/p>","DOI":"10.21203\/rs.3.rs-10093990\/v1","type":"posted-content","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:57:37Z","timestamp":1784995057000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk-Stratified versus Cytology-Based Triage of Non-HPV 16\/18-Positive for Detection of High-Grade Cervical Intraepithelial Neoplasia: Protocol of a Non- Inferiority Randomized Controlled Trial"],"prefix":"10.21203","author":[{"given":"Kehinde S.","family":"OKUNADE","sequence":"first","affiliation":[{"name":"University of Lagos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omolola","family":"SALAKO","sequence":"additional","affiliation":[{"name":"University of Lagos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaiah","family":"SOIBI-HARRY","sequence":"additional","affiliation":[{"name":"Case Western Reserve University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iyabo Y.","family":"ADEMUYIWA","sequence":"additional","affiliation":[{"name":"University of Lagos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosimot O.","family":"DAVIES","sequence":"additional","affiliation":[{"name":"University of Lagos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah M.","family":"HABEEBU-ADEYEMI","sequence":"additional","affiliation":[{"name":"Lagos University Teaching Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"ADEBOJE-JIMOH","sequence":"additional","affiliation":[{"name":"Lagos University Teaching Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ololade","family":"ADERETI","sequence":"additional","affiliation":[{"name":"Lagos University Teaching Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayomide I.","family":"FAYINTO","sequence":"additional","affiliation":[{"name":"University of Lagos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temitope V.","family":"ADEKANYE","sequence":"additional","affiliation":[{"name":"Lagos University Teaching Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teniola","family":"LAWANSON","sequence":"additional","affiliation":[{"name":"University of Lagos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oziegbe","family":"OGHIDE","sequence":"additional","affiliation":[{"name":"Lagos University Teaching Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayokunle M.","family":"OLUMODEJI","sequence":"additional","affiliation":[{"name":"Lagos State University Teaching Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hameed","family":"ADELABU","sequence":"additional","affiliation":[{"name":"University of Lagos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muisi A.","family":"Adenekan","sequence":"additional","affiliation":[{"name":"Lagos State University Teaching Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modupe","family":"Adedeji","sequence":"additional","affiliation":[{"name":"Lagos State University Teaching Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adebola A.","family":"ADEJIMI","sequence":"additional","affiliation":[{"name":"University of Lagos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Festus O.","family":"OLOWOSELU","sequence":"additional","affiliation":[{"name":"University of Lagos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"ALLSOP","sequence":"additional","affiliation":[{"name":"University of Leeds"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose I.","family":"ANORLU","sequence":"additional","affiliation":[{"name":"University of Lagos"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"BEREK","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2020."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","author":"Singh D","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health 2022. https:\/\/doi.org\/10.1016\/S2214-109X(22)00501-0"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s44197-022-00081-1","article-title":"The Study on Cervical Cancer Burden in 127 Countries and Its Socioeconomic Influence Factors","volume":"13","author":"Xu T","year":"2022","unstructured":"Xu T, Yang X, He X, Wu J. The Study on Cervical Cancer Burden in 127 Countries and Its Socioeconomic Influence Factors. J Epidemiol Glob Health. 2022;13:154\u201361. https:\/\/doi.org\/10.1007\/s44197-022-00081-1.","journal-title":"J Epidemiol Glob Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.coi.2021.03.006","article-title":"Reflection: burden of cervical cancer in Sub-Saharan Africa and progress with HPV vaccination","volume":"71","author":"Ngcobo N","year":"2021","unstructured":"Ngcobo N, Jaca A, Iwu-Jaja CJ, Mavundza E. Reflection: burden of cervical cancer in Sub-Saharan Africa and progress with HPV vaccination. Curr Opin Immunol. 2021;71:21\u20136. https:\/\/doi.org\/10.1016\/j.coi.2021.03.006.","journal-title":"Curr Opin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.5195\/ijms.2023.2369","article-title":"Attitude, and Prevalence Towards Cervical Cancer Screening Among Women in a Nigerian Urban Municipality","author":"Daniel FM","year":"2023","unstructured":"Daniel FM, Ike WI, Gbuchie Anurika M, Udofia James S, Chinyere Kalu P, Ebizo Ikpa S, Knowledge. Attitude, and Prevalence Towards Cervical Cancer Screening Among Women in a Nigerian Urban Municipality. Int J Med Students. 2023;S91. https:\/\/doi.org\/10.5195\/ijms.2023.2369.","journal-title":"Int J Med Students"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","article-title":"Human papillomavirus and cervical cancer","volume":"40","author":"Okunade KS","year":"2020","unstructured":"Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol (Lahore). 2020;40:602\u20138. https:\/\/doi.org\/10.1080\/01443615.2019.1634030.","journal-title":"J Obstet Gynaecol (Lahore)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright TC","year":"2015","unstructured":"Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015;136:189\u201397. https:\/\/doi.org\/10.1016\/j.ygyno.2014.11.076.","journal-title":"Gynecol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2147\/RMHP.S296914","article-title":"An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation","volume":"15","author":"Okunade KS","unstructured":"Okunade KS, Adejimi AA, John-Olabode SO, Oshodi YA, Oluwole AA. An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation. Risk Manag Healthc Policy 2022;Volume 15:1823\u201330. https:\/\/doi.org\/10.2147\/RMHP.S296914","journal-title":"Risk Manag Healthc Policy 2022;Volume"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ypmed.2016.11.030","article-title":"Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening","volume":"98","author":"Tota JE","year":"2017","unstructured":"Tota JE, Bentley J, Blake J, Coutl\u00e9e F, Duggan MA, Ferenczy A, et al. Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening. Prev Med (Baltim). 2017;98:15\u201320. https:\/\/doi.org\/10.1016\/j.ypmed.2016.11.030.","journal-title":"Prev Med (Baltim)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3802\/jgo.2021.32.e86","article-title":"Evaluation of partial genotyping with HPV16\/18 for triage of HPV positive, cytology negative women in the COMPACT study","author":"Hanley SJB","year":"2021","unstructured":"Hanley SJB, Fujita H, Aoyama-Kikawa S, Kasamo M, Torigoe T, Matsuno Y, et al. Evaluation of partial genotyping with HPV16\/18 for triage of HPV positive, cytology negative women in the COMPACT study. J Gynecol Oncol. 2021;32. https:\/\/doi.org\/10.3802\/jgo.2021.32.e86.","journal-title":"J Gynecol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/ijc.28425","article-title":"Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa","volume":"134","author":"Denny L","year":"2014","unstructured":"Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer. 2014;134:1389\u201398. https:\/\/doi.org\/10.1002\/ijc.28425.","journal-title":"Int J Cancer"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.7314\/APJCP.2014.15.14.5879","article-title":"Prevalence of High Risk Human Papillomavirus Infection with Different Cervical Cytological Features among Women Undergoing Health Examination at the National Cancer Institute, Thailand","volume":"15","author":"Laowahutanont P","year":"2014","unstructured":"Laowahutanont P, Karalak A, Wongsena M, Loonprom K, Pukcharoen P, Jamsri P, et al. Prevalence of High Risk Human Papillomavirus Infection with Different Cervical Cytological Features among Women Undergoing Health Examination at the National Cancer Institute, Thailand. Asian Pac J Cancer Prev. 2014;15:5879\u201382. https:\/\/doi.org\/10.7314\/APJCP.2014.15.14.5879.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000527905","article-title":"Cervical Epithelial Abnormalities and Associated Factors among HIV-Infected Women in Lagos, Nigeria: A Cytology-Based Study","volume":"2022","author":"Okunade KS","unstructured":"Okunade KS, Badmos KB, Soibi-Harry AP, Garba S-R, Ohazurike EO, Ozonu O et al. Cervical Epithelial Abnormalities and Associated Factors among HIV-Infected Women in Lagos, Nigeria: A Cytology-Based Study. Acta Cytol 2022:1\u20139. https:\/\/doi.org\/10.1159\/000527905","journal-title":"Acta Cytol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/modpathol.2017.16","article-title":"Evaluation of p16\/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women","volume":"30","author":"Ebisch RM","year":"2017","unstructured":"Ebisch RM, van der Horst J, Hermsen M, Rijstenberg LL, Vedder JE, Bulten J, et al. Evaluation of p16\/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women. Mod Pathol. 2017;30:1021\u201331. https:\/\/doi.org\/10.1038\/modpathol.2017.16.","journal-title":"Mod Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2019.1634030","article-title":"Human papillomavirus and cervical cancer","author":"Okunade KS","year":"2019","unstructured":"Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol (Lahore). 2019. https:\/\/doi.org\/10.1080\/01443615.2019.1634030.","journal-title":"J Obstet Gynaecol (Lahore)"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11604\/pamj.2017.28.227.13979","article-title":"Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the outpatient clinics of a university teaching hospital in Lagos, Nigeria","volume":"28","author":"Okunade KS","year":"2017","unstructured":"Okunade KS, Nwogu CM, Oluwole AA, Anorlu RI. Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the outpatient clinics of a university teaching hospital in Lagos, Nigeria. Pan Afr Med J. 2017;28:1\u20137. https:\/\/doi.org\/10.11604\/pamj.2017.28.227.13979.","journal-title":"Pan Afr Med J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/cncy.21521","article-title":"The Pap test and Bethesda 2014","volume":"123","author":"Nayar R","year":"2015","unstructured":"Nayar R, Wilbur DC. The Pap test and Bethesda 2014. Cancer Cytopathol. 2015;123:271\u201381. https:\/\/doi.org\/10.1002\/cncy.21521.","journal-title":"Cancer Cytopathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1037\/1082-989X.6.4.317","article-title":"The use of multiple imputation for the analysis of missing data","volume":"6","author":"Sinharay S","year":"2001","unstructured":"Sinharay S, Stern HS, Russell D. The use of multiple imputation for the analysis of missing data. Psychol Methods. 2001;6:317\u201329.","journal-title":"Psychol Methods"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","article-title":"Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Canfell K","year":"2020","unstructured":"Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395:591\u2013603. https:\/\/doi.org\/10.1016\/S0140-6736(20)30157-4.","journal-title":"Lancet"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10093990\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10093990\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:12:50Z","timestamp":1788858770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10093990\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":19,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10093990\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,7,25]]},"subtype":"preprint"}}